PARIS — New 6-month and 1-year data from the EnligHTN I first-in-man study demonstrate safety and efficacy of the multielectrode renal denervation system in patients with drug-resistant hypertension.
The prospective, multicenter, feasibility EngligHTN I trial enrolled 46 patients (mean age, 60 years; mean BMI, 32) who were taking at least three antihypertensive medications including a diuretic. Mean baseline BP was 176 mm Hg/96 mm Hg.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.